Israeli radiology startup Aidoc has received FDA clearance for its AI-based product meant to help identify potential cases of pulmonary embolism in chest CT scans. Pulmonary embolism (PE) – which occurs when a blood clot gets lodged in the lung – is considered a silent killer that causes up to 200,000 deaths a year in the United States. The condition often strikes with little to no warning and diagnosis of a case can be extremely time-sensitive. Aidoc's technology doesn't require dedicated hardware and runs continuously on hospital systems, automatically ingesting radiological images. The 70-person company focuses on workflow optimization in radiology to help triage high risk patients for additional and faster review.
May-20-2019, 20:20:19 GMT